Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CJRB-101 |
Synonyms | |
Therapy Description |
CJRB-101 is a bacterial strain that potentially induces repolarization of M2 to M1 macrophages leading to activation of CD8-positive T-cells and decreased tumor growth (Cancer Res (2023) 83 (7_Supplement): 6433). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CJRB-101 | CJRB101|CJRB 101 | CJRB-101 is a bacterial strain that potentially induces repolarization of M2 to M1 macrophages leading to activation of CD8-positive T-cells and decreased tumor growth (Cancer Res (2023) 83 (7_Supplement): 6433). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|